menu
    • menu

    Company profile for Innoviva

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva, Inc. (NASDAQ: INVA) is focused on royalty management. Innoviva’s portfolio includes the respiratory assets partnered with Glaxo Group Limited (“GSK”), including RELVAR®/BREO® ELLIPTA® (flutica...
    Innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva, Inc. (NASDAQ: INVA) is focused on royalty management. Innoviva’s portfolio includes the respiratory assets partnered with Glaxo Group Limited (“GSK”), including RELVAR®/BREO® ELLIPTA® (fluticasone furoate/ vilanterol, “FF/VI”), ANORO® ELLIPTA® (umeclidinium bromide/ vilanterol, “UMEC/VI”) and TRELEGY® ELLIPTA® (the combination FF/UMEC/VI).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InnovivaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1350 Old Bayshore Highway Suite 400 Burlingame, CA 94010
    Telephone
    Telephone
    650-238-9600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://inva.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/innoviva
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innoviva's Q4, Full-Year 2025 Results Highlight Company Progress
    Innoviva's Q4, Full-Year 2025 Results Highlight Company Progress

    25 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260225055287/en/Innoviva-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Highlights-Recent-Company-Progress

    BUSINESSWIRE
    25 Feb 2026
    Share Share
    Innoviva Joins Oppenheimer Healthcare Life Sciences Conference
    Innoviva Joins Oppenheimer Healthcare Life Sciences Conference

    19 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260219756566/en/Innoviva-to-Participate-in-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference

    BUSINESSWIRE
    19 Feb 2026
    Share Share
    Innoviva Joins 37Th Piper Sandler Healthcare Conference
    Innoviva Joins 37Th Piper Sandler Healthcare Conference

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125545821/en/Innoviva-to-Participate-in-the-37th-Annual-Piper-Sandler-Healthcare-Conference

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    Innoviva Unveils Q3 2025 Financials, Showcases Recent Progress
    Innoviva Unveils Q3 2025 Financials, Showcases Recent Progress

    05 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251105298339/en/Innoviva-Reports-Third-Quarter-2025-Financial-Results-Highlights-Recent-Company-Progress

    BUSINESSWIRE
    05 Nov 2025
    Share Share
    Innoviva Specialty Therapeutics Presents Zoliflodacin Phase 3
    Innoviva Specialty Therapeutics Presents Zoliflodacin Phase 3

    20 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-20/innoviva-specialty-therapeutics-announces-oral-presentation-featuring-new-analyses-from-the-zoliflod

    PHARMIWEB
    20 Oct 2025
    Share Share
    Innoviva to Participate in Upcoming Investor Conferences
    Innoviva to Participate in Upcoming Investor Conferences

    26 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-26/innoviva-to-participate-in-upcoming-investor-conferences

    PHARMAWEB
    26 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search